Adherence to inhaled treatments is a complex challenge for patients with chronic obstructive
pulmonary disease (COPD) and asthma, it not only involves following the prescribed …

Pulmonary diseases affect more than 500 million people globally and are the leading
causes of death and disability worldwide [1]. A variety of therapeutic options, such as dry …

Inhalable medications for patients with asthma and chronic obstructive pulmonary disease
(COPD) can be confusing even for health care professionals because of the multitude of …

Compliance with the prescribed inhaler dosage regimen and the manufacturer's
recommended inhalation technique are essential to achieve good control in asthma and …

Dry powder inhalers (DPIs) are essential in treating patients with pulmonary diseases. Since
DPIs were introduced in the 1960s, a remarkable improvement has been made in their …

During the last decades, the term “drug delivery systems”(DDSs) has almost fully replaced
previously used terms, such as “dosage forms”, in an attempt to emphasize the importance …

Inability to use inhaler devices correctly is a major source of non-compliance in patients with
asthma. The problem of coordinating dose release with inspiration seen with pressurised …

Optimal management of asthma and chronic obstructive pulmonary disease requires that the
patient complies with inhaled drug treatments and that there is a successful interaction …

Originating from the observations of the child of a 3M laboratories executive, who suggested
that her own asthma treatment could be given like a perfume spray, metered dose inhalers …

Poor adherence with inhaled therapy presents a considerable problem. In the UK, non‐
adherence is estimated to occur in 10–46% of those prescribed inhaled corticosteroids and …